Capital Planning Advisors LLC Buys 779 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Capital Planning Advisors LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 6.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 13,515 shares of the healthcare conglomerate’s stock after buying an additional 779 shares during the quarter. UnitedHealth Group makes up 1.1% of Capital Planning Advisors LLC’s holdings, making the stock its 25th biggest holding. Capital Planning Advisors LLC’s holdings in UnitedHealth Group were worth $6,837,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. APG Asset Management US Inc. boosted its holdings in UnitedHealth Group by 5.3% in the second quarter. APG Asset Management US Inc. now owns 351,983 shares of the healthcare conglomerate’s stock valued at $174,108,000 after acquiring an additional 17,747 shares during the last quarter. Ameriprise Financial Inc. grew its stake in UnitedHealth Group by 0.6% during the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock worth $1,920,039,000 after purchasing an additional 21,149 shares during the period. Employees Retirement System of Texas grew its position in shares of UnitedHealth Group by 9.2% during the 2nd quarter. Employees Retirement System of Texas now owns 198,670 shares of the healthcare conglomerate’s stock worth $101,175,000 after buying an additional 16,800 shares during the period. Eminence Capital LP acquired a new position in shares of UnitedHealth Group during the 2nd quarter valued at $26,657,000. Finally, Drucker Wealth 3.0 LLC bought a new stake in UnitedHealth Group in the second quarter valued at $1,062,000. 87.86% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Up 1.8 %

Shares of UnitedHealth Group stock opened at $528.94 on Friday. The stock has a market capitalization of $486.77 billion, a P/E ratio of 34.12, a P/E/G ratio of 1.41 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock’s 50-day simple moving average is $543.52 and its 200 day simple moving average is $563.78. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the business posted $5.83 earnings per share. The business’s quarterly revenue was up 6.8% on a year-over-year basis. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.74 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.59%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.19%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of recent research reports. Stephens raised their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Morgan Stanley dropped their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $627.74.

View Our Latest Research Report on UnitedHealth Group

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.